New research data surrounding the medication Retatrutide , specifically the high-dose formulation ZPHC ZPHC, indicate a impressive benefit on physique reduction and associated metabolic conditions . Scientists posit that this innovative compound, targeting both GLP-1 and GIP pathways , may provide a major breakthrough in the approach of overweight